Cinoxacin

In the US, Cinoxacin (cinoxacin systemic) is a member of the following drug classes: quinolones, urinary anti-infectives and is used to treat Bladder Infection.

US matches:

• Cinoxacin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MB06

CAS registry number (Chemical Abstracts Service)

0028657-80-9

Chemical Formula

C12-H10-N2-O5

Molecular Weight

262

Therapeutic Categories

Antiinfective, quinolin-derivative

Antibacterial: Gyrase inhibitor

Chemical Name

[1,3]Dioxolo[4,5-g]cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-

Foreign Names

• Cinoxacinum (Latin)
• Cinoxacin (German)
• Cinoxacine (French)
• Cinoxacino (Spanish)

Generic Names

• Cinoxacin (OS: BAN, JAN, USAN)
• Cinoxacina (OS: DCIT)
• Cinoxacine (OS: DCF)
• 64716 (IS: Lilly)
• Cinoxacin (PH: USP 32)

Brand Names

• Arukibact
  Choseido Pharmaceutical, Japan



• Cinobac
  Bruno, Italy; Lilly, Kenya; Lilly, Tanzania; Lilly, Uganda



• Cinobactin
  Lilly, Greece; Lilly, Kenya; Lilly, Tanzania; Lilly, Uganda



• Cinocil
  Farma1, Italy



• Cinoxen
  Ibirn, Italy



• Iristan-V
  Biostam, Greece



• Mecicon
  Chung Mei, Taiwan



• Tatsulexin
  Tatsumi Kagaku, Japan



• Uroc
  Lampugnani, Italy



• Urocinox
  D & G, Italy

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.